Showing results (21-30 of 297) with videos related to
Sort By:
Pageof 30
Cancers|March 11, 2023
Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and ResistanceCurtis A Lachowiez, Courtney D DiNardo, Sanam LoghaviHistopathology|January 6, 2015
Epstein-Barr virus-positive plasmacytoma in immunocompetent patientsSanam Loghavi, Joseph D Khoury, L Jeffrey MedeirosBlood Reviews|December 1, 2023
Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemiaDaniel J Chandra, Curtis A Lachowiez, Sanam LoghaviCurrent Hematologic Malignancy Reports|July 27, 2019
Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of CancerHanadi El Achi, Joseph D Khoury, Sanam LoghaviAmerican Journal of Clinical Pathology|August 16, 2015
B-acute lymphoblastic leukemia/lymphoblastic lymphomaSanam Loghavi, Jeffery L Kutok, Jeffrey L JorgensenBMJ Case Reports|July 21, 2016
Resolution of lung adenocarcinoma after discontinuation of ibrutinibTamer Khashab, Sanam Loghavi, Sergej N Konoplev, et al.Journal of Hematology & Oncology|March 28, 2014
Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemiaShilpan Shah, Sanam Loghavi, Guillermo Garcia-Manero, et al.Hematology. American Society of Hematology. Education Program|December 5, 2025
Demystifying the diagnosis and management of ICUS, CHIP, and CCUSZhuoer Xie, Dae Hyun Lee, Doris K Hansen, et al.Current Hematologic Malignancy Reports|May 4, 2021
Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and BeyondSiba El Hussein, Joseph D Khoury, L Jeffrey Medeiros, et al.Leukemia|November 4, 2024
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?Firas El Chaer, Anthony J Perissinotti, Sanam Loghavi, et al.Pageof 30